Work

GLP ‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: A systematic review and meta‐analysis

FWCI: 1.304
Cites: 34
Cited by: 86
Related to: 10